ACUTE RESPIRATORY DISTRESS SYNDROME: Potential Pharmacologic Interventions
- 1 September 2000
- journal article
- review article
- Published by Elsevier BV in Clinics in Chest Medicine
- Vol. 21 (3), 563-587
- https://doi.org/10.1016/s0272-5231(05)70167-2
Abstract
No abstract availableKeywords
This publication has 156 references indexed in Scilit:
- Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytesCritical Care Medicine, 1996
- Acute Respiratory Distress Syndrome: Potential Therapeutic InterventionsSeminars in Respiratory and Critical Care Medicine, 1994
- Prostacyclin for the Treatment of Pulmonary Hypertension in the Adult Respiratory Distress SyndromeAnesthesiology, 1990
- A Multicenter Randomized, Placebo-Controlled Trial of Surfactant Therapy for Respiratory Distress SyndromeNew England Journal of Medicine, 1989
- Tissue Destruction by NeutrophilsNew England Journal of Medicine, 1989
- High-Dose Corticosteroids in Patients with the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1987
- Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic SepsisNew England Journal of Medicine, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- The Effects of High-Dose Corticosteroids in Patients with Septic ShockNew England Journal of Medicine, 1984
- Elastolytic Activity in Pulmonary Lavage Fluid from Patients with Adult Respiratory-Distress SyndromeNew England Journal of Medicine, 1981